Exploration of a prognostic signature for mitochondria-related genes and the therapeutic prospects of vorinostat in clear cell renal cell carcinoma
The constructed prognostic signature provides a valuable tool for patient prognosis prediction. Vorinostat emerges as a promising therapeutic candidate for high-risk ccRCC patients, contributing to a deeper understanding of ccRCC biology and personalized therapeutic interventions.
Authors
- Bao Zhou (ORCID: https://orcid.org/0000-0002-8082-3503)
- Jin‐Lai Gao (ORCID: https://orcid.org/0009-0004-0106-1451)
- Lili Shi (ORCID: https://orcid.org/0000-0001-7938-1907)
- Bin Shen (ORCID: https://orcid.org/0000-0002-8946-8448)
- Yao Zhang (ORCID: https://orcid.org/0000-0002-6509-0946)
- Jing Jin (ORCID: https://orcid.org/0009-0002-3774-6546)
- Nan Li (ORCID: https://orcid.org/0000-0003-1553-0015)
- Yifang Cao
- Huan Pan
- Wenhui Li (ORCID: https://orcid.org/0009-0002-2557-6615)
- Yi He (ORCID: https://orcid.org/0000-0003-4511-5461)
Institutions
- Zhejiang Sci-Tech University (CN)
- Jiaxing University (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tau-24-565
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52